Keros Therapeutics, Inc. ("Keros" or the "Company") (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing ...
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today reported financial results for the fourth quarter and year ended December 31, 2024, and ...
Sumo 相撲 is currently in previews at The Public Theater 's Anspacher Theater ahead of a March 5 opening night. Get a first look at the Ma-Yi Theater Company, La Jolla Playhouse, and Public Theater ...
Grifols revenue and EBITDA growth, improved leverage ratio, and significant liquidity highlight its resilience and potential ...
We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...
(NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today reported financial results for the year ended December 31, 2024 and highlighted recent ...
Robust financial performance driven by full year 2024 royalty revenue growth of 28%Reiterating 2025 financial guidance of $180-$200 million in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback